For example, miR-660—which targets ALOX15B in cervical cancer cells [205]—also attenuates the expression of Mdm2 in lung cancer cells [87], thereby releasing p53 from the negative regulation and hence, augmenting the level of ALOX15B expression. Here, ALOX15B is linked to lung carcinoma.